Laetitia Dunogeant

510 total citations
6 papers, 322 citations indexed

About

Laetitia Dunogeant is a scholar working on Genetics, Oncology and Immunology. According to data from OpenAlex, Laetitia Dunogeant has authored 6 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 3 papers in Oncology and 2 papers in Immunology. Recurrent topics in Laetitia Dunogeant's work include Chronic Lymphocytic Leukemia Research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Fungal Infections and Studies (1 paper). Laetitia Dunogeant is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Fungal Infections and Studies (1 paper). Laetitia Dunogeant collaborates with scholars based in France. Laetitia Dunogeant's co-authors include Laetitia Coutte, S. Le Burel, Anne-Laure Voisin, Aurélien Marabelle, Olivier Lambotte, Xavier Mariette, O. Fain, Rakiba Belkhir, Alexandra Léary and Benjamin Besse and has published in prestigious journals such as Annals of the Rheumatic Diseases, European Journal of Cancer and British Journal of Dermatology.

In The Last Decade

Laetitia Dunogeant

6 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laetitia Dunogeant France	3	262	98	56	50	42	6	322
Mazen Nasrallah United States	7	170 0.6×	36 0.4×	140 2.5×	41 0.8×	22 0.5×	14	290
Tawnie Braaten United States	5	165 0.6×	68 0.7×	40 0.7×	25 0.5×	22 0.5×	7	249
Javed Gill United States	7	116 0.4×	94 1.0×	46 0.8×	13 0.3×	144 3.4×	12	290
Hirotsugu Ariizumi Japan	10	158 0.6×	24 0.2×	78 1.4×	44 0.9×	38 0.9×	26	246
Lina Odqvist Sweden	6	150 0.6×	44 0.4×	92 1.6×	31 0.6×	157 3.7×	10	290
Eduardo Ríos Spain	10	77 0.3×	73 0.7×	56 1.0×	22 0.4×	109 2.6×	32	221
Zdravko Mitrović Croatia	10	117 0.4×	95 1.0×	51 0.9×	20 0.4×	160 3.8×	30	255
Benjamin Garmezy United States	8	84 0.3×	21 0.2×	19 0.3×	63 1.3×	27 0.6×	35	211
Edgardo R. Parrilla Castellar United States	6	93 0.4×	24 0.2×	41 0.7×	48 1.0×	110 2.6×	9	257
James E. Radford United States	6	84 0.3×	34 0.3×	29 0.5×	36 0.7×	42 1.0×	8	209

Countries citing papers authored by Laetitia Dunogeant

Since Specialization

Citations

This map shows the geographic impact of Laetitia Dunogeant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laetitia Dunogeant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laetitia Dunogeant more than expected).

Fields of papers citing papers by Laetitia Dunogeant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laetitia Dunogeant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laetitia Dunogeant. The network helps show where Laetitia Dunogeant may publish in the future.

Co-authorship network of co-authors of Laetitia Dunogeant

This figure shows the co-authorship network connecting the top 25 collaborators of Laetitia Dunogeant. A scholar is included among the top collaborators of Laetitia Dunogeant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laetitia Dunogeant. Laetitia Dunogeant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Couderc, Marion, René‐Marc Flipo, Jérémie Sellam, et al.. (2024). NSAID exposure delays time-to-pregnancy in patients with spondyloarthritis: an analysis of the GR2 prospective cohort. RMD Open. 10(4). e004745–e004745. 1 indexed citations

2.

Guen, Pierre Le, Raphaël Borie, Marie Legendre, et al.. (2023). NKX2.1mutation revealed by a lymphoid interstitial pneumonia in an adult with rheumatoid arthritis. ERJ Open Research. 9(3). 682–2022. 1 indexed citations

3.

Belkhir, Rakiba, S. Le Burel, Laetitia Dunogeant, et al.. (2017). Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment. Annals of the Rheumatic Diseases. 76(10). 1747–1750. 165 indexed citations

4.

Burel, S. Le, Stéphane Champiat, Christine Mateus, et al.. (2017). Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis. European Journal of Cancer. 82. 34–44. 148 indexed citations

5.

Belkhir, Rakiba, S. Le Burel, Olivier Lambotte, et al.. (2017). OP0004 Rheumatoid arthritis occuring after immune checkpoint inhibitors. Annals of the Rheumatic Diseases. 76. 51–52. 2 indexed citations

6.

Allardet-Servent, Jérôme, et al.. (2015). Disseminated histoplasmosis partially mimicking a dermatomyositis in a patient with rheumatoid arthritis. British Journal of Dermatology. 173(3). 797–800. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact